-transparent.png){kind=logo}
Cisplatin (cis-platinum, 100 mg/m2) and fluorouracil (1000 mg/m2/d), for 120 hours' infusion every three weeks for three courses, produced a 93% overall response rate and a 54% complete clinical response at the single-institution level. The same combination was tested in the Radiation Therapy Oncology Group to evaluate the effectiveness and feasibility of this combination. An overall response rate of 86% was obtained, with a 38% complete clinical response. Only 27 of 42 patients completed planned surgery. Compliance with chemotherapy and radiation therapy was substantially better. No additional morbidity after surgical resection or postoperative radiation therapy was identified as secondary to the induction chemotherapy. We conclude that the combination of cisplatin and fluorouracil infusion is effective, with high complete clinical response rate in patients with advanced, previously untreated head and neck carcinoma.
J R Jacobs, and
T F Pajak, and
J Kinzie, and
M Al-Sarraf, and
L Davis, and
G A Hanks, and
I Weigensberg, and
S Leibel
March 1979,
Cancer treatment reports,
J R Jacobs, and
T F Pajak, and
J Kinzie, and
M Al-Sarraf, and
L Davis, and
G A Hanks, and
I Weigensberg, and
S Leibel
October 1987,
American journal of clinical oncology,
J R Jacobs, and
T F Pajak, and
J Kinzie, and
M Al-Sarraf, and
L Davis, and
G A Hanks, and
I Weigensberg, and
S Leibel
January 1994,
Auris, nasus, larynx,
J R Jacobs, and
T F Pajak, and
J Kinzie, and
M Al-Sarraf, and
L Davis, and
G A Hanks, and
I Weigensberg, and
S Leibel
January 2000,
Rays,
J R Jacobs, and
T F Pajak, and
J Kinzie, and
M Al-Sarraf, and
L Davis, and
G A Hanks, and
I Weigensberg, and
S Leibel
January 1994,
Acta oncologica (Stockholm, Sweden),
J R Jacobs, and
T F Pajak, and
J Kinzie, and
M Al-Sarraf, and
L Davis, and
G A Hanks, and
I Weigensberg, and
S Leibel
January 1988,
Head & neck surgery,
J R Jacobs, and
T F Pajak, and
J Kinzie, and
M Al-Sarraf, and
L Davis, and
G A Hanks, and
I Weigensberg, and
S Leibel
January 1995,
Tumori,
J R Jacobs, and
T F Pajak, and
J Kinzie, and
M Al-Sarraf, and
L Davis, and
G A Hanks, and
I Weigensberg, and
S Leibel
December 2012,
Medical oncology (Northwood, London, England),
J R Jacobs, and
T F Pajak, and
J Kinzie, and
M Al-Sarraf, and
L Davis, and
G A Hanks, and
I Weigensberg, and
S Leibel
January 2011,
The Gulf journal of oncology,
J R Jacobs, and
T F Pajak, and
J Kinzie, and
M Al-Sarraf, and
L Davis, and
G A Hanks, and
I Weigensberg, and
S Leibel
June 1995,
Journal of surgical oncology,
